Case Study: Renovia achieves lower-cost, high-compliance virtual urogynecology trial with ObvioHealth

Renovia delivers a fully virtual urogynecology trial with ObvioHealth, achieving 93.5% ePRO compliance

Renovia, a medical device company, faced the challenge of conducting a clinical trial for an at-home device treating urinary incontinence during the COVID-19 pandemic. Their target demographic of older women was hesitant to attend in-person site visits, and there was no precedent for a fully virtual trial in the urogynecology field. They partnered with ObvioHealth to design and manage a remote study that could ensure patient safety, provide device training, and recruit a hard-to-reach population.

ObvioHealth implemented a fully virtual trial using its proprietary mobile app and its Clinical Oversight and Coordination Hub (COACH) team for support. The solution included digital recruitment, multi-format patient training, and real-time data capture for increased accuracy. The study delivered statistically significant results with 89% retention and 93.5% ePRO compliance, all at a recruitment cost ten times lower than traditional methods.

Renovia